Recent Company News

• 10:00 AM ET Mar 24, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (147 total)

• 10:03 AM ET Mar 20, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (155 total)

• 12:10 PM ET Mar 18, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX +3.3% to $23.10; S&P 500 (0.6%) to $6,678.99

• 07:14 AM ET Mar 17, 2026
  

  Follow-up: Bicycle Therapeutics reports Q4 results; announces strategic reprioritization including ~30% workforce reduction ($5.05, 0.00)

• 07:04 AM ET Mar 17, 2026
  

  Bicycle Therapeutics reports Q4 EPS ($0.29) vs year-ago ($0.75) ($5.05, 0.00)

• 10:02 AM ET Feb 17, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (210 total)

• 09:53 AM ET Feb 05, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (208 total)

• 03:09 PM ET Feb 03, 2026
  

  Bicycle Therapeutics trading lower following company's leadership change announcement ($5.98, -0.52)

• 07:05 AM ET Feb 03, 2026
  

  Bicycle Therapeutics announces leadership transitions ($6.49, 0.00)

• 12:17 PM ET Jan 16, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX (1.4%) to $15.62; S&P 500 +0.2% to $6,955.87